These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1066 related items for PubMed ID: 22247563

  • 1. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y, Aritaka N, Setoguchi Y, Ito Y, Kimura H, Hamano Y, Sugimoto K, Komatsu N.
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N, Kato S, Nakamura S.
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K.
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 6. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A, Kanegane H, Kasahara Y.
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK, Kim JH, Sung JY, Han JH, Ko YH, Hematopathology Study Group of the Korean Society of Pathologists.
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [Abstract] [Full Text] [Related]

  • 10. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [Abstract] [Full Text] [Related]

  • 11. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF, Wu QL, Zong YS.
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H.
    Rev Med Virol; 2006 Nov; 16(4):251-61. PubMed ID: 16791843
    [Abstract] [Full Text] [Related]

  • 14. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
    Gottschalk S.
    Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
    [No Abstract] [Full Text] [Related]

  • 15. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L, Wang H, Wang JH, Xia ZJ, Lu Y, Huang HQ, Jiang WQ, Zhang YJ.
    Oncotarget; 2015 Oct 06; 6(30):30317-26. PubMed ID: 26210287
    [Abstract] [Full Text] [Related]

  • 16. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec 06; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.
    Eur J Immunol; 2006 Mar 06; 36(3):593-602. PubMed ID: 16479544
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R.
    Clin Cancer Res; 2012 Aug 01; 18(15):4183-90. PubMed ID: 22675173
    [Abstract] [Full Text] [Related]

  • 19. Extranodal NK/T-cell lymphoma, nasal type, possibly arising from chronic Epstein-Barr virus infection.
    Seishima M, Yuge M, Kosugi H, Nagasaka T.
    Acta Derm Venereol; 2010 Aug 01; 90(1):102-3. PubMed ID: 20107744
    [No Abstract] [Full Text] [Related]

  • 20. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K.
    Arch Dermatol; 2006 May 01; 142(5):587-95. PubMed ID: 16702496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.